Ultrasonically induced hyperthermia for adjunctive treatment of intraocular malignant melanoma

Retina

Volumn 17, Issue 2, 1997, Pages 109-117

  Coleman, D Jackson ^a,b   Silverman, Ronald H ^a,b   Ursea, Roxana ^a,b   Rondeau, Mark J ^a,b   Lizzi, Frederic L ^c  

^a Department of Molecular Biology and Genetics   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c RIVERSIDE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENUCLEATION; EYE CANCER; HUMAN; HYPERTHERMIC THERAPY; MELANOMA; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0030907993     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199703000-00005     Document Type: Article

References (33)

1. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells. Br J Ophthalmol 1978;62:420-425.
2. Petrovich Z, Pike M, Astrahan MA, et al. Episcleral plaque thermoradiotherapy of posterior uveal melanomas. Am J Oncol 1996;19:207-211.
3. Overgaard J, Gonzales Gonzales D, Hulshof MC, et al. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995;345:540-543.
4. Augsburger JJ, Lauritzen K, Gamel JW, et al. Matched group study of preenucleation radiotherapy versus enucleation alone for primary malignant melanoma of the choroid and ciliary body. Am J Clin Oncol 1990;13:382-387.
5. Kreissig I, Rohrbach M, Lincoff H. Irradiation of choroidal melanomas before enucleation? Retina 1989;9:101-104.
6. Luyten GPM, Mooy CM, Eijkenboom WMH, et al. No demonstrated effect of preenucleation irradiation on survival of patients with uveal melanoma. Am J Ophthalmol 1995; 119:786-791.
7. Rosberger DF, Coleman DJ, Silverman RH, et al. Immunomodulation in choroidal melanoma: Reversal of inverted CD4/CD8 ratios following treatment with ultrasonic hyperthermia. Biotechnol Ther 1994;5:59-68.
8. Huang XQ, Mitchell MS, Liggett PE, et al. Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol Immunother 1994;38:399-405.
9. Steeves RA, Tompkins DT, Nash RN, et al. Thermoradiotherapy of intraocular tumors in an animal model: Concurrent versus sequential brachytherapy and ferromagnetic hyperthermia. Int J Radiat Oncol Biol Phys 1995;33:659-662.
10. Song CW, Rhee JG, Levitt SH. Blood flow in normal tissues and tumors during hyperthermia. J Natl Cancer Inst 1980;64:119-124.
11. Dellian M, Walenta S, Kuhnle G, et al. Relation between autoradiographically measured blood flow and ATP concentrations obtained from imaging bioluminescence in tumors following hyperthermia. Int J Cancer 1993;53:785-791.
12. Overgaard J, Nielsen OS, Lindegaard JC. Biological basis for rational design of clinical treatment with combined hyperthermia and radiation. In: Field SB, Franconi C, eds. Physics and Technology of Hyperthermia. NATO ASI Series E: Applied Sciences - No. 12 7. Dordrecht, Boston, Lancester: Martinus Nijhoff Publishers, 1987:54-79.
13. Mieler WF, Steeves R, Tomkins R, et al. Concurrent versus sequential ferromagnetic hyperthermia and iodine-125 brachytherapy in the management of melanoma in an animal model. Invest Ophthalmol Vis Sci 1995;36(Suppl): S393.
14. Coleman DJ, Lizzi FL, Burgess SEP, et al. Ultrasonic hyperthermia and radiation in the management of intraocular malignant melanoma. Am J Ophthalmol 1986;101:635-642.
15. Coleman DJ, Silverman RH, Iwamoto T, et al. Histopathologic effects of ultrasonically induced hyperthermia in intraocular malignant melanoma. Ophthalmology 1988;95:970-981.
16. Liggett PE, Colin MA, Astrahan M, et al. Combined localized current field hyperthermia and irradiation for intraocular tumors. Ophthalmology 1991;98:1830-1836.
17. Finger PT. Microwave thermoradiotherapy for intraocular melanoma. Am J Clin Oncol 1996;19:281-289.
18. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995;113:315-321.
19. Mieler WF, Jaffe GJ, Steeves R. Ferromagnetic hyperthermia and Iodine-125 brachytherapy in the treatment of choroidal melanoma in a rabbit model. Arch Ophthalmol 1989;107:1524-1528.
20. Lizzi FL, Driller J, Lunzer B, et al. Computer model of ultrasonic hyperthermia and ablation for ocular tumors using B-mode data. Ultrasound Med Biol 1992;18:59-73.
21. Lizzi FL, Driller J, Kalicz A, Coleman DJ. Computer simulations of ultrasonic heating for ocular therapy. Acta Ophthalmologica Suppl 1992;204:40-45.
22. Kramer MS. Clinical Epidemiology and Biostatistics: A Primer for Clinical Investigators and Decision-Makers. Berlin Heidelberg: Springer-Verlag, 1988:179-181.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Roy Stat Soc 1958;53:457-481.
24. Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance and their relevance to clinical hyperthermia. Int J Hyperthermia 1995;11:459-488.
25. Overgaard J, Bartelink H. About tolerance and quality: An important notice to all radiation oncologists (editorial). Radiother Oncol 1995;35:1-3.
26. Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187-202.
27. Kidd MN, Lyness RW, Patterson CC, et al. Prognostic factors in malignant melanoma of the choroid: A retrospective survey of cases in Northern Ireland between 1965 and 198 0. Trans Ophthalmol Soc UK 1986; 105:114-119.
28. Coleman DJ, Silverman RH, Rondeau MJ, et al. Correlations of acoustic tissue typing of malignant melanoma and histopathologic features as a predictor of death. Am J Ophthalmol 1990;110:380-388.
29. Coleman DJ, Silverman RH, Rondeau MJ, et al. Ultrasonic tissue characterization of uveal melanoma and prediction of patient survival after enucleation and brachytherapy. Am J Ophthalmol 1991;112:682-688.
30. Quivey JM, Augsburger J, Snelling L, Brady LW. 125-I plaque therapy for uveal melanoma: Analysis of the impact of time and dose factors on local control. Cancer 1996; 77:2356-2362.
31. Miller DW. A review of proton beam radiation therapy. Med Phys 1995;22:1943-1954.
32. Augsburger JJ, Gamel JW. Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 1990;66:1596-1600.
33. Manschot WA, Van Strik R. Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results. Br J Ophthalmol 1987;71:348-352.